Myriad Genetics Inc (NASDAQ:MYGN)

BATS BZX Real-Time Price
As of 11:35am ET
 +0.75 / +2.73%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Myriad Genetics Inc have a median target of 26.50, with a high estimate of 34.00 and a low estimate of 14.00. The median estimate represents a -6.13% decrease from the last price of 28.23.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Hold stock in Myriad Genetics Inc. This rating has held steady since February, when it was upgraded from a Sell rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 47.97%
Growthannually -132.45%


Growthquarterly 65.69%
Growthannually 2.31%
Key to the earnings and sales forecast charts.